Biocure Technology Inc.
CCSE:CUREShare Statistics
As of December 31, 2025, Biocure Technology Inc. has 20.21M shares outstanding.
| Shares Outstanding | 20.21M |
Financial Position
As of December 31, 2025, Biocure Technology Inc. maintains a current ratio of 0.10, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.73, indicating elevated leverage, while an interest coverage ratio of -8.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt / Equity | 3.73 |
| Debt / EBITDA | -0.65 |
| Interest Coverage | -8.56 |
Financial Efficiency
Over the twelve months ended December 31, 2025, Biocure Technology Inc. posted a negative return on equity (ROE) of -7.05, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.14, reflecting losses generated across the asset base.
| Return on Equity (ROE) | -7.05 |
| Return on Assets (ROA) | -5.14 |
Stock Splits
Biocure Technology Inc.'s most recent stock split took place on October 28, 2024 with a 9:1 split ratio.
| Last Split Date | 10/28/2024 |
| Split Ratio | 9:1 |
Scores
As of December 31, 2025, Biocure Technology Inc. has an Altman Z-Score of -17.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -17.05 |